证券代码：301584 证券简称：建发致新 公告编号：2025-009 上海建发致新医疗科技集团股份有限公司 关于增加2025年度向银行申请综合授信额度的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 2025年10月24日，上海建发致新医疗科技集团股份有限公司（以下简称"公司" ）召开第三届董事会第十次会议及第三届监事会第九次会议，审议通过了《关于增 加2025年度向银行申请综合授信额度的议案》，该议案尚需提交公司股东大会审议。 现将相关内容公告如下： 1 在上述授信额度内办理具体授信业务时，授权对应主体的法定代表人根据公司有关 规定签署相关法律文件。上述授权有效期至公司2025年年度股东大会召开之日止。 一、已审批的综合授信额度的情况 公司于2025年3月28日召开第三届董事会第八次会议及第三届监事会第七次会 议，并于2025年4月18日召开2024年年度股东大会审议通过了《关于公司2025年度 向银行申请综合授信的议案》，同意公司及控股子公司2025年度向银行申请综合授 信总额度不超过110亿元（人民币，下同）。截止2025年9月30日，公司及控股 ...

- The report tracks the recent IPO market performance, focusing on the net gains from new stock listings across the Sci-Tech Innovation Board, ChiNext, and Main Board, assuming all stocks are successfully subscribed and sold at the market average price on the first trading day, excluding lock-up restrictions[1][11][39] - The cumulative IPO net gains for A-class accounts with a scale of 2 billion reached 2.44%, while B-class accounts of the same scale achieved 2.19% as of October 24, 2025[11][39] - For larger accounts with a scale of 10 billion, the IPO net gains were significantly lower, with A-class accounts at 0.77% and B-class accounts at 0.70%[11][39] - The average first-day price increase for Sci-Tech Innovation Board stocks was 218.45%, while ChiNext stocks saw an average increase of 244.28%[1][16] - The report provides detailed calculations for theoretical IPO gains, using formulas such as: $ Full subscription quantity = Maximum subscription limit × Average offline subscription rate $ $ Full subscription gains = (First-day average price - IPO price) × Full subscription quantity $[35][39] - The highest full subscription gains among recent IPOs were achieved by United Power, Jindal Zhixin, and C Marco, with gains of 50.81, 12.58, and 11.03 million yuan respectively[35][38] - The report also includes monthly tracking of IPO gains for A-class accounts across different scales, showing a cumulative gain rate of 6.17% for 2 billion accounts since 2024, and 2.44% for 2025 alone[39][41] - Similar tracking for B-class accounts reveals a cumulative gain rate of 5.11% for 2 billion accounts since 2024, and 2.19% for 2025 alone[47][45] - The report highlights the IPO subscription process, including strategic placement, offline inquiry, and online pricing methods, with detailed statistics on subscription rates, oversubscription multiples, and effective subscription ratios for recent IPOs like Xi'an Yicai and Bibet[24][25]

证券日报网讯建发致新（301584）10月27日在互动平台回答投资者提问时表示，公司目前没有脑机接口 类产品的销售，没有相关的技术研发和储备。 ...

具体来看，今日上榜的营业部中，共有6家机构专用席位现身，即买一、买二、买三、买四、卖一、卖 二、卖三、卖四、卖五，合计买入金额1.11亿元，卖出金额1.64亿元，合计净卖出5283.14万元。 近半年该股累计上榜龙虎榜7次，上榜次日股价平均涨1.88%，上榜后5日平均涨12.95%。 资金流向方面，今日该股主力资金净流入407.43万元，其中，特大单净流入1061.50万元，大单资金净流 出654.07万元。近5日主力资金净流入4020.64万元。（数据宝） 建发致新今日上涨10.18%，全天换手率62.54%，成交额11.42亿元，振幅17.90%。龙虎榜数据显示，机 构净卖出5283.14万元，营业部席位合计净买入1307.45万元。 深交所公开信息显示，当日该股因日换手率达62.54%上榜，机构专用席位净卖出5283.14万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交2.89亿元，其中，买入成交额为1.25亿 元，卖出成交额为1.64亿元，合计净卖出3975.68万元。 | 买/ 卖 | | 会员营业部名称 | 买入金额（万元） | 卖出金额（万元） | | --- | --- | - ...

Market Overview - The pharmaceutical commercial sector increased by 0.32% compared to the previous trading day, with Jianfa Zhixin leading the gains [1] - The Shanghai Composite Index closed at 3996.94, up 1.18%, while the Shenzhen Component Index closed at 13489.4, up 1.51% [1] Stock Performance - Jianfa Zhixin (301584) closed at 39.29, up 10.18% with a trading volume of 315,400 shares and a transaction value of 1.142 billion [1] - Run Da Medical (603108) closed at 15.30, up 3.66% with a trading volume of 180,900 shares and a transaction value of 274 million [1] - Other notable performers include Huaren Health (301408) up 2.28%, and Saili Medical (603716) up 1.98% [1] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 6.1445 million from institutional investors, while retail investors saw a net inflow of 56.1279 million [2] - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors increased their positions [2] Individual Stock Capital Flow - Run Da Medical saw a significant net outflow of 49.9539 million from institutional investors, indicating a bearish sentiment [3] - Conversely, Jiuzhoutong (866000) had a net inflow of 16.7641 million from institutional investors, suggesting positive interest [3] - Other stocks like Nanjing Medical (600713) and Huaren Health (301408) also showed varying degrees of net inflows and outflows from different investor categories [3]

格隆汇10月27日丨建发致新(301584.SZ)在投资者互动平台表示，公司目前没有脑机接口类产品的销 售，没有相关的技术研发和储备。 ...

建发致新(301584)10月27日在互动平台表示，公司目前没有脑机接口类产品的销售，也没有相关的技术 研发和储备。 ...

Core Viewpoint - In the past week, 51 stocks had a turnover rate exceeding 100%, indicating significant trading activity in the market [1] Group 1: High Turnover Stocks - Yunhan Chip City (301563) had the highest weekly turnover rate at 277.04% [1] - Haocreat Ruitong (301668), Daosheng Tianhe (601026), and Jianda Zhixin (301584) also reported turnover rates exceeding 200% [1] Group 2: Industry Analysis - The stocks with turnover rates above 100% predominantly belong to the electronics, machinery equipment, pharmaceutical biology, and petroleum and petrochemical industries [1]

Core Viewpoint - The stock of Jianfa Zhixin experienced a decline of 4.14% on the trading day, with a high turnover rate of 67.68% and a total transaction amount of 1.289 billion yuan, indicating significant trading activity and volatility in the market [2] Trading Activity - The stock was listed on the Dragon and Tiger List due to its turnover rate reaching 67.68%, with institutional investors net buying 20.82 million yuan [2] - The top five trading departments accounted for a total transaction amount of 365 million yuan, with a buying amount of 155 million yuan and a selling amount of 209 million yuan, resulting in a net selling of 53.70 million yuan [2] - Among the trading departments, five institutional special seats were involved, with a total buying amount of 155 million yuan and a selling amount of 134 million yuan, leading to a net buying of 20.82 million yuan [2] Fund Flow - The stock saw a net outflow of 97.42 million yuan from main funds, with a significant outflow of 92.29 million yuan from large orders and 0.51 million yuan from medium orders [2] - Over the past five days, the main funds experienced a net inflow of 21.54 million yuan [2] Historical Performance - In the past six months, the stock has appeared on the Dragon and Tiger List six times, with an average price increase of 0.22% the day after being listed and an average increase of 6.73% over the following five days [2]

（原标题：73只A股筹码大换手（10月24日）） 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 | 证券代码 | 证券简称 | 收盘价（元） | 换手率 | 涨跌幅 | | --- | --- | --- | --- | --- | | | | | （%） | （%） | | 603175 | C超颖 | 84.99 | 83.73 | 397.60 | | 301584 | 建发致新 | 35.66 | 67.68 | -4.14 | | 301563 | 云汉芯城 | 233.32 | 55.47 | -1.60 | | 002278 | 神开股份 | 14.44 | 53.44 | 6.49 | | 301668 | 昊创瑞通 | 62.45 | 51.86 | -9.88 | | 001386 | C马可波 | 28.54 | 50.77 | -9.25 | | 301231 | 荣信文化 | 37.83 | 46.23 | -0.53 | | 920158 | 长江能科 | 18.98 | 43.34 | 0.48 | | 601026 | 道生天合 | 26.39 | 41.58 ...